• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肝门部胆管癌相比,肝内胆管癌的预后更好吗?

Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma?

机构信息

Division of General Surgery A, Department of Surgery, University of Verona Medical School, 37134 Verona, Italy.

出版信息

J Surg Oncol. 2010 Feb 1;101(2):111-5. doi: 10.1002/jso.21452.

DOI:10.1002/jso.21452
PMID:19953578
Abstract

BACKGROUND AND OBJECTIVES

Cholangiocarcinoma can be classified as intrahepatic (ICC) or perihilar (PCC). The objectives of this study is to evaluate the surgical outcomes of patients with PCC and ICC, identify the main prognostic factors related to survival and compare the outcome and the prognostic factors of PCC and ICC.

METHODS

Ninety-five out of 152 patients observed between January 1990 and December 2007 at Surgical Division of University of Verona Medical School underwent the resection of ICC (33 patients) or PCC (62 patients).

RESULTS

Overall median survival was 24 months with a 3- and 5-year survival rate of 45% and 23%, respectively. Prognostic factors for survival were macroscopic types of the tumor, the resection of extrahepatic bile duct, radical resection, lymph node metastases, and macro-vascular invasion. Survival was related with the macroscopic type of the tumors with a 5-year survival rate of 26% and 13% for ICC and PCC, respectively. Univariate analysis identified that negative clinico-pathological factors where significant more frequently found in PCC compared to ICC.

CONCLUSION

We identified that ICC have longer survival rate compared to PCC. PCC showed a higher frequency of negative clinico-pathological factors such as non-radical (R+) resection, perineural infiltration and macro-vascular invasion.

摘要

背景与目的

胆管癌可分为肝内型(ICC)或肝门周围型(PCC)。本研究旨在评估 PCC 和 ICC 患者的手术结果,确定与生存相关的主要预后因素,并比较 PCC 和 ICC 的结果和预后因素。

方法

1990 年 1 月至 2007 年 12 月,在维罗纳大学医学院外科部观察到的 152 名患者中有 95 名接受了 ICC(33 名患者)或 PCC(62 名患者)切除术。

结果

总体中位生存期为 24 个月,3 年和 5 年生存率分别为 45%和 23%。生存的预后因素包括肿瘤的大体类型、肝外胆管切除、根治性切除、淋巴结转移和大血管侵犯。生存与肿瘤的大体类型有关,ICC 和 PCC 的 5 年生存率分别为 26%和 13%。单因素分析表明,与 ICC 相比,PCC 中阴性临床病理因素更为常见。

结论

我们发现 ICC 的生存率高于 PCC。PCC 显示出更高频率的阴性临床病理因素,如非根治性(R+)切除、神经周围浸润和大血管侵犯。

相似文献

1
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma?与肝门部胆管癌相比,肝内胆管癌的预后更好吗?
J Surg Oncol. 2010 Feb 1;101(2):111-5. doi: 10.1002/jso.21452.
2
Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.肿块型肝内胆管癌的外科治疗:一项针对107例患者的11年西方单中心经验。
Ann Surg Oncol. 2009 Feb;16(2):404-12. doi: 10.1245/s10434-008-0227-1. Epub 2008 Nov 27.
3
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.肝内胆管癌的长期预后及预后因素。
Chin Med J (Engl). 2009 Oct 5;122(19):2286-91.
4
What prognostic factors are important for resected intrahepatic cholangiocarcinoma?对于接受手术切除的肝内胆管癌,哪些预后因素至关重要?
J Gastroenterol Hepatol. 2008 May;23(5):766-70. doi: 10.1111/j.1440-1746.2007.05040.x. Epub 2007 Sep 12.
5
The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.肝内胆管细胞癌手术后的预后和生存结果:淋巴结转移和淋巴结清扫与生存的关系。
Ann Surg Oncol. 2009 Nov;16(11):3048-56. doi: 10.1245/s10434-009-0631-1. Epub 2009 Jul 22.
6
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.肝切除术后肝内胆管癌的预后因素:单因素和多因素分析
Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.
7
Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.手术切缘状态对无淋巴结转移的孤立肿块型肝内胆管癌肝切除术的临床影响
J Surg Oncol. 2007 Aug 1;96(2):160-5. doi: 10.1002/jso.20792.
8
The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.肝内胆管癌患者手术治疗的影响及不良预后因素:60例患者的回顾性分析
Anticancer Res. 2008 Jul-Aug;28(4C):2353-9.
9
Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.肝内胆管癌肝切除术后组织病理学预后因素的回顾性分析
Cancer J. 2009 May-Jun;15(3):257-61. doi: 10.1097/PPO.0b013e31819e3312.
10
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.肝内胆管癌的外科治疗结果及影响生存的临床病理因素
Br J Surg. 2002 Dec;89(12):1525-31. doi: 10.1046/j.1365-2168.2002.02268.x.

引用本文的文献

1
Comparison of prognostic factors and their differences in intrahepatic, hilar, and distal cholangiocarcinoma: A systematic review and meta-analysis.肝内、肝门部和肝外胆管癌预后因素及其差异的比较:一项系统评价和荟萃分析。
World J Gastrointest Oncol. 2025 Jul 15;17(7):107995. doi: 10.4251/wjgo.v17.i7.107995.
2
Neuroendocrine Component in Extrahepatic Cholangiocarcinoma is Associated with Better Survival: Data from the SEER Study.肝外胆管癌中的神经内分泌成分与更好的生存率相关:来自监测、流行病学和最终结果(SEER)研究的数据
Adv Ther. 2023 Sep;40(9):4032-4041. doi: 10.1007/s12325-023-02597-9. Epub 2023 Jul 11.
3
Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort.
肝外和肝内胆管癌手术后的生存情况:一项基于人群的队列研究。
BMJ Open. 2022 Apr 12;12(4):e049789. doi: 10.1136/bmjopen-2021-049789.
4
Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma.评估欧洲肝门部胆管癌分期系统的临床适用性。
J Gastrointest Surg. 2016 Apr;20(4):741-7. doi: 10.1007/s11605-016-3075-5. Epub 2016 Jan 22.
5
Biliary stenting for unresectable cholangiocarcinoma: A population-based study of long-term outcomes and hospital costs in Taiwan.不可切除胆管癌的胆道支架置入术:一项基于台湾人群的长期结局和医院费用研究。
Kaohsiung J Med Sci. 2015 Jul;31(7):370-6. doi: 10.1016/j.kjms.2015.05.001. Epub 2015 Jun 10.
6
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.胆管癌的多基因突变谱分析确定了可采取行动的分子亚组。
Oncotarget. 2014 May 15;5(9):2839-52. doi: 10.18632/oncotarget.1943.
7
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.肝门部和肝内胆管癌外科治疗中淋巴结清扫的模式和预后意义。
J Gastrointest Surg. 2013 Nov;17(11):1917-28. doi: 10.1007/s11605-013-2331-1. Epub 2013 Sep 19.
8
Intrahepatic cholangiocarcinoma: clinicopathological differences between peripheral type and hilar type.肝内胆管细胞癌:周围型与肝门型的临床病理差异。
J Gastrointest Surg. 2012 Mar;16(3):540-8. doi: 10.1007/s11605-011-1730-4. Epub 2011 Oct 20.
9
A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.一种与胆汁淤积相关的胆管癌的小鼠模型及其进展涉及的转录因子。
Gastroenterology. 2011 Jul;141(1):378-88, 388.e1-4. doi: 10.1053/j.gastro.2011.03.044. Epub 2011 Mar 24.
10
Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma.肝门周围胆管癌切除术后淋巴结比率的预后意义。
HPB (Oxford). 2011 Apr;13(4):240-5. doi: 10.1111/j.1477-2574.2010.00277.x. Epub 2011 Jan 28.